Osteoporosis International

, Volume 16, Supplement 2, pp S8–S17

Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland

Original Article


The aim of this study was to estimate the hospitalization incidence and the total number of hospital days related to all fractures and osteoporotic fractures in the year 2000 in Switzerland and to compare these with data from other frequent disorders in men and women. The official administrative and medical statistics database of the Swiss Federal Office of Statistics (SFOS) from the year 2000 was used. It covered 81.2% of all registered patient admissions and was considered to be representative of the entire population. We included the ICD-10 codes of 84 diagnoses that were compatible with an underlying osteoporosis and applied the best matching age-specific osteoporosis attribution rates published for the ICD-9 diagnosis codes to the individual ICD-10 codes. To preserve comparability with previously published data from 1992, we grouped the data related to the ICD-10 fracture codes into seven diagnosis pools (fractures of the axial skeleton, fractures of the proximal upper limbs, fractures of the distal upper limbs, fractures of the proximal lower limbs, fractures of the distal lower limbs, multiple fractures, and osteoporosis) and analyzed them separately for women and men by age group. Incidences of hospitalization due to fractures were calculated, and the direct medical costs related to hospitalization were estimated. In addition, we compared the results with those from chronic pulmonary obstructive disease (COPD), stroke, acute myocardial infarction, heart failure, diabetes and breast carcinoma from the same database. In Switzerland during 2000, 62,535 hospitalizations for fractures (35,586 women and 26,949 men) were registered. Fifty-one percent of all fractures in women and 24% in men were considered as osteoporotic. The overall incidences of hospitalization due to fractures were 969 and 768 per 100,000 in women and men, respectively. The hospitalization incidences for fractures of the proximal lower limbs and the axial skeleton increased exponentially after the age of 65 years. The direct medical cost of hospitalization of patients with osteoporosis and/or related fractures was 357 million CHF. Hip fractures accounted for approximately half of these costs in women and men. Among other common diseases in women and men, osteoporosis ranked number 1 in women and number 2 (behind COPD) in men. When compared with data from 1992, the average length of stay had shortened by 8.4 days for women and 4.7 days for men, leading to a decrease of almost 40% in direct medical costs related to acute hospitalizations. This apparent decrease in cost might result from a shift into the ambulatory cost segment, for which the assessment and management tools need to be developed. We conclude that, in 2000, osteoporosis continued to be a heavy burden on the Swiss healthcare system. Lack of awareness of the disease and its consequences prevents widespread use of drugs with anti-fracture efficacy. This limits their potential to reduce costs.


Costs Epidemiology Fractures Hospitalizations Men Osteoporosis 


  1. 1.
    Anonymous (1993) Consensus development conference. Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med 94:646–650CrossRefPubMedGoogle Scholar
  2. 2.
    Melton LJ III (1988) Epidemiology of fractures. In: Riggs BL, Melton LJ (eds) Osteoporosis: etiology, diagnosis and management. Raven Press, New York, pp 133–155Google Scholar
  3. 3.
    Nilsson BE (1969) Age and incidence of ankle fractures. Acta Orthop Scand 40:122–129PubMedGoogle Scholar
  4. 4.
    Melton LJ III, Sampson JM, Morrey BF, Illstrup DM (1981) Epidemiologic features of pelvic fractures. Clin Orthop 155:43–47Google Scholar
  5. 5.
    Rose SH, Melton LJ III, Morrey BF, Illstrup DM, Riggs BL (1982) Epidemiologic features of humeral fractures. Clin Orthop 168:24–30PubMedGoogle Scholar
  6. 6.
    Seeley DG, Browner WS, Nevitt MC, Genant HK, Scott JC, Cummings SR (1991) Which fractures are associated with low appendicular bone mass in elderly women? Ann Intern Med 115:837–842PubMedGoogle Scholar
  7. 7.
    Lippuner K, von Overbeck J, Perrelet R, Bosshard H, Jaeger P (1997) Incidence and direct medical costs of hospitalizations due to osteoporotic fractures in Switzerland. Osteoporos Int 7:414–425PubMedGoogle Scholar
  8. 8.
    Phillips S, Fox N, Jacobs J, Wright WE (1988) The direct medical cost of osteoporosis for American women aged 45 and older, 1986. Bone 9:271–279CrossRefPubMedGoogle Scholar
  9. 9.
    Melton LJ III, Thamer M, Ray NF, et al (1997) Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation. J Bone Miner Res 12:16–23PubMedGoogle Scholar
  10. 10.
    Simonen O (1988) Epidemiology and socio-economic aspects of osteoporosis in Finland. Ann Chir Gynaecol 77:173–175PubMedGoogle Scholar
  11. 11.
    Cummings SR, Rubin SM, Black D (1990) The future of hip fractures in the United States. Numbers, costs, and potential effects of postmenopausal estrogen. Clin Orthop 252:163–166PubMedGoogle Scholar
  12. 12.
    Melton LJ III, O’Fallon WM, Riggs BL (1987) Secular trends in the incidence of hip fractures. Calcif Tissue Int 41:57–64PubMedGoogle Scholar
  13. 13.
    Melton LJ III (1993) Hip fractures: a worldwide problem today and tomorrow. Bone 14 [Suppl 1]:S1–8Google Scholar
  14. 14.
    Hoffenberg R, James OFW, Brocklehurst JC, et al (1989) Fractured neck of the femur: prevention and management: summary and recommendations of a report of the Royal College of Physicians. J R Coll Physicians Lond 23:8–12PubMedGoogle Scholar
  15. 15.
    Lippuner K, Jaeger P (1998) Direkte Spitalkosten durch osteoporosebedingte Hüftfrakturen in der Schweiz heute und im Jahre 2020. Ein sozio-ökonomischer Alptraum. Schweiz Aerztezeitung 79:690–697Google Scholar
  16. 16.
    Black DM, Thompson D, Bauer DC, Ensrud K, et al. (2000) Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. J Clin Endocrinol Metab 85:4118–4124CrossRefPubMedGoogle Scholar
  17. 17.
    Black, DM, Cummings SR, Karpf DB, et al (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535–1541CrossRefPubMedGoogle Scholar
  18. 18.
    Cummings SR, Black DM, Thompson DE, et al. (1998) Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 280:2077–2082CrossRefPubMedGoogle Scholar
  19. 19.
    McClung MR, Geusens P, Miller PD, et al (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344:333–340CrossRefPubMedGoogle Scholar
  20. 20.
    Chapuy MC, Arlot ME, Delmas PD, Meunier PJ (1994) Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 308:1081–1082PubMedGoogle Scholar
  21. 21.
    Chapuy MC, Arlot ME, Duboeuf F, et al (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327:1637–1642PubMedGoogle Scholar
  22. 22.
    Chevalley T, Rizzoli R, Nydegger V, et al (1994) Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporos Int 4:245–252PubMedGoogle Scholar

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2004

Authors and Affiliations

  1. 1.Osteoporosis PoliclinicUniversity Hospital of BerneBerneSwitzerland
  2. 2.HealthEcon AGBasleSwitzerland

Personalised recommendations